A Bristol-Myers Squibb Company (BMY) and AstraZeneca PLC (AZN) Diabetes Trial is a "Dud"
6/19/2013 7:07:22 AM
More...
|
AstraZeneca PLC (AZN) Announces New $500 Million Cambridge Biomedical Campus HQ, Will Employ 2000 by 2016
6/18/2013 7:06:18 AM
More...
|
AstraZeneca PLC (AZN) and NGM Biopharmaceuticals, Inc. Form Diabetes/Obesity Partnership
6/17/2013 7:09:16 AM
More...
|
AstraZeneca PLC (AZN) and Bristol-Myers Squibb Company (BMY) to Present New Data at American Diabetes Association 73rd Scientific Sessions®
6/14/2013 7:07:53 AM
More...
|
Amgen (AMGN) and AstraZeneca PLC (AZN) Highlight Data to be Presented at European League Against Rheumatism Annual Meeting
6/12/2013 6:47:12 AM
More...
|
AstraZeneca PLC (AZN) in Deal for Pearl Therapeutics Worth Up to $1.15 Billion
6/10/2013 7:21:23 AM
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Receives $10 Million Milestone Payment
6/6/2013 7:14:30 AM
More...
|
FDA Grants Priority Review to Bristol-Myers Squibb Company (BMY) and AstraZeneca PLC (AZN)’s Metreleptin, an Investigational Agent for Treatment of Metabolic Disorders Associated With Rare Forms of Lipodystrophy
6/4/2013 10:11:27 AM
More...
|
AstraZeneca PLC (AZN) Settles With Hanmi Pharmaceutical, Co., Ltd and Amneal Pharmaceuticals Over Nexium; Prepares for Olaparib Regulatory Filing
6/4/2013 7:33:18 AM
More...
|
AstraZeneca PLC (AZN) Scraps Rigel Pharmaceuticals, Inc. (RIGL) Arthritis Pill in New R&D Blow, Astra to Write Off $140 Million Charge
6/4/2013 7:23:02 AM
More...
|
|